Ambulatory Surgical Center Market is estimated to be valued at USD 104.44 Bn in 2025 and is expected to reach USD 139.3 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.
The ambulatory surgical center market demand is steadily increasing due to the rising preference for cost-effective, patient-centric surgical care outside traditional hospital settings. Ambulatory Surgical Centers (ASCs) offer streamlined services, reduced hospital stays, and quicker recovery times, making them an attractive option for both patients and payers. The growing adoption of minimally invasive surgical procedures, supported by technological advancements in equipment and diagnostics, is significantly enhancing the capabilities of ASCs.
Furthermore, government policies and reimbursement models are increasingly favorable toward outpatient care, encouraging hospitals and private investors to expand their ASC networks. The market is also witnessing growth in single-specialty and multi-specialty ASCs, particularly in fields such as orthopedics, ophthalmology, and cardiovascular surgery. Additionally, the expansion of telehealth, digital integration, and robotic-assisted surgeries is helping ASCs offer high-quality care with greater operational efficiency. These factors collectively contribute to the strong upward trend in ambulatory surgical center market demand globally.
|
Current Event |
Description and Its Impact |
|
Regulatory and Payment Policy Changes in Key Markets |
|
|
Market Expansion Drivers and Investment Trends |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The integration of artificial intelligence into ambulatory surgical center has significantly transforming the operations and clinical efficiency of Ambulatory Surgical Centers (ASCs) by enhancing decision-making, streamlining workflows, and improving patient outcomes. AI algorithms analyze patient histories, lab results, and imaging to predict surgical risks and determine eligibility for outpatient procedures. This ensures only low-risk patients are scheduled for ASC-based surgeries, reducing cancellations and complications. AI-powered scheduling tools automate appointment slots, align surgical teams, and optimize operating room usage, helping ASCs maximize throughput and reduce wait times. AI is automating coding, billing, and documentation tasks, reducing clerical errors and administrative burden, thereby improving compliance and reimbursement efficiency.
For instance, Oath Surgical has emerged from stealth with an innovative end‑to‑end model for ambulatory surgical centers (ASCs), centered on its proprietary AI-powered operating system, OathOS, launched alongside company-owned centers in Portland. The system integrates AI-assisted scribing, automated charting, and post-operative recovery management across the patient journey.
In terms of center type, the multispecialty centers segment is estimated to hold 65.0% of the maket share in 2025, due to their ability to offer a wide range of surgical procedures under one roof, making them more efficient, profitable, and convenient for both patients and healthcare providers. Unlike single-specialty centers, multispecialty ASCs can accommodate various specialties such as orthopedics, gastroenterology, ophthalmology, urology, and general surgery, which allows for better resource utilization and higher patient throughput.
From a clinical perspective, they attract a larger and more diverse patient base, improving scheduling flexibility and maximizing the use of expensive surgical infrastructure and staff. For patients, these centers offer the advantage of consolidated care, reduced wait times, and continuity across procedures without needing multiple hospital visits. Additionally, insurers and government payers support them due to lower operational costs compared to hospital-based outpatient departments.
In March 2025, Compass Surgical Partners collaborated with the Orthopaedic Institute of North Texas and Lam Vascular & Associates to develop the “Frisco Station Surgery Center,” a multispecialty ambulatory surgery center (ASC). The 12,000‑sq-ft facility, opening in late 2026, will feature four operating rooms offering orthopedic, spine, podiatry, pain management, cardiovascular, endovascular and other services, with planned AAAHC accreditation.
In terms of modality, the hospital-based ambulatory surgical center segment is estimated to hold the largest market share in 2025, due to a combination of operational, clinical, and financial advantages. Unlike freestanding ASCs, hospital-based centers benefit from seamless integration with inpatient care services, advanced diagnostic support, and emergency backup, which makes them more appealing for complex or higher-risk procedures. Hospitals are increasingly leveraging ASCs to offload low-acuity surgical volume from main facilities, helping reduce congestion, optimize resource use, and cut operational costs.
Moreover, hospital-based ASCs often enjoy stronger negotiating power with payers and insurers, allowing them to secure more favorable reimbursement rates. They also adhere to rigorous accreditation and compliance standards, which builds greater patient trust and physician confidence. As value-based care models grow, hospitals are positioning ASCs as strategic assets to improve outcomes, enhance patient experience, and expand service reach. These factors are driving significant growth in hospital-based ASC demand, particularly in urban and semi-urban healthcare ecosystems.
In April 2024, AdventHealth Daytona Beach inaugurated its new 60,000 sq ft medical office building and hospital-based ambulatory surgery center (ASC). The facility includes four operating rooms, two catheterization labs, and clinics for cardiac rehabilitation and surgical care. This $45.7 million joint venture with Meadows & Ohly reflects the growing trend toward bringing ASC services in-house for greater cost-efficiency and integrated patient care. Such developments are propelling the ambulatory surgical center market share.
In terms of services, the diagnostics services segment is estimated to hold the highest share of the market in 2025, due to their efficiency, convenience, and ability to offer timely, cost-effective care. These centers are designed for outpatient procedures, and diagnostic services such as endoscopy, colonoscopy, imaging, and biopsies are critical components of many pre-surgical and preventive care pathways. By offering diagnostics on-site, ASCs reduce the need for hospital visits, shorten waiting times, and streamline patient care, particularly for early disease detection and elective surgeries.
Moreover, the integration of diagnostics into ASCs aligns with the growing trend of value-based healthcare, where early, accurate diagnosis improves outcomes while reducing overall costs. Technological advancements such as portable imaging equipment, digital pathology, and real-time data sharing further enhance the efficiency of diagnostic services in these centers. As a result, ASCs are becoming a preferred choice for both patients and healthcare providers seeking accessible, high-quality diagnostic care outside traditional hospital systems.
For instance, New ambulatory center at Johnson Memorial Hospital’s Enfield campus includes diagnostic imaging, CT, X‑ray, mammography, bone density scans, and ultrasounds, plus four ORs and two procedure rooms, better addressing outpatient surgery and diagnostic demand
In terms of specialty area, the orthopedic segment is expected to dominate the global ambulatory surgical center market with a greatest share in 2025. Orthopedic surgeries such as joint arthroscopy, ligament repair, and minor joint replacements are often minimally invasive, making them well-suited for outpatient settings. ASCs offer shorter wait times, lower procedural costs, and faster recovery, which aligns with patient expectations for elective orthopedic treatments. Additionally, advancements in surgical tools, anesthesia, and post-operative care have made it possible to safely perform many orthopedic interventions outside of hospitals.
Payers also favor orthopedic procedures in ASCs due to their cost-efficiency, often reimbursing at lower rates than hospital outpatient departments while maintaining high clinical outcomes. Surgeons benefit from greater control over scheduling and equipment, further encouraging a shift to ASC settings. As musculoskeletal conditions continue to rise, especially in aging populations, the ambulatory surgical center market growth for orthopedic care is expected to remain strong, driven by both clinical effectiveness and economic value.
In June 2025, Smith+Nephew and Standard Health teamed up to launch the UK’s first Orthopaedic Ambulatory Surgery Centre (ASC) in Poole, Dorset. The new facility will serve both NHS and private patients, offering advanced procedures such as rotator cuff repair, ACL reconstruction, and hip and knee replacements.
To learn more about this report, Download Free Sample
North America dominates the global ambulatory surgical center market, holding an estimated share of 43.70% in 2025. The growth in North America market is primarily driven by a combination of healthcare system dynamics, regulatory support, and patient preferences. One of the primary drivers is the rising pressure to reduce healthcare costs while maintaining high-quality outcomes. ASCs offer a more affordable alternative to hospital-based surgeries, often delivering procedures at significantly lower costs. This cost-effectiveness is highly appealing to both public and private payers in the U.S. and Canada.
Additionally, the aging population in North America is increasing the need for surgical interventions, particularly in specialties like orthopedics, ophthalmology, and cardiovascular care—areas where ASCs are highly active. In April 2025, Pixee Medical, a leader in Augmented Reality (AR) navigation for orthopedic procedures, received FDA 510(k) clearance for its Knee+ NexSight system — an advanced AR guidance tool for total knee replacement surgeries. This next-generation solution is specifically developed to meet the rising demand within ambulatory surgical centers (ASCs).
The Asia Pacific region is expected to exhibit the fastest growth in the global ambulatory surgical center market due to several converging factors. The region is experiencing rapid urbanization and an expanding middle-class population, which increases the need for accessible, cost-effective surgical care. ASCs provide a convenient alternative to overcrowded public hospitals and expensive private hospitals, especially in countries like India, China, and Southeast Asian nations. Secondly, there is growing awareness and acceptance of day-care surgeries and minimally invasive procedures, which aligns with the ASC model.
Governments across the region are also actively promoting healthcare infrastructure development, including public-private partnerships to establish modern outpatient centers. In countries like India, policy reforms such as the Ayushman Bharat initiative are creating greater insurance coverage for procedures that can be performed in ASCs. Additionally, the shortage of inpatient beds and the increasing burden of chronic conditions, such as cataracts, orthopedic issues, and cardiovascular diseases are pushing healthcare providers to adopt more scalable and efficient outpatient solutions.
Technological advancements, particularly in robotic surgery, telemedicine, and diagnostic tools, are enabling ASCs in Asia Pacific to handle complex procedures with high precision. As a result, the ambulatory surgical center market demand in the region is poised for strong growth, driven by affordability, scalability, and healthcare modernization.
The United States leads the Ambulatory Surgical Center Market Demand due to its high hospital care costs, favorable insurance reimbursements, and well-established outpatient infrastructure. ASCs offer cost-effective, efficient alternatives to inpatient procedures, making them attractive to patients, providers, and insurers alike. Medicare and private payers support the shift toward outpatient care, especially for specialties like orthopedics, ophthalmology, gastroenterology, and pain management therapeutics. Additionally, advancements in minimally invasive surgery and anesthesia enable complex procedures to be safely performed in ASCs. Physician ownership models and integration with health systems further drive growth and innovation across the U.S. market.
India is witnessing strong growth in the ambulatory surgical center market demand due to rapid urbanization, a growing middle class, and government-backed health schemes like Ayushman Bharat, which expand access to outpatient surgical care. ASCs offer cost-effective solutions for high-volume procedures such as cataract surgeries, ENT treatments, diagnostics, and basic orthopedics, helping to reduce pressure on overcrowded hospitals. Private players are increasingly investing in ASCs thanks to their lower setup costs and quicker returns. With growing digital integration and patient preference for quicker recovery, ASCs are becoming a key component of India’s evolving healthcare landscape.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 104.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.2% | 2032 Value Projection: | USD 139.3 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
AmSurg Corp., HCA Holdings, Inc., Tenet Healthcare, Surgical Care Affiliates, Inc., Surgery Partners, Ambulatory Surgical Centers of America, Heathway Medical Group, Community Health Systems, Inc., and Vision Group Holdings |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The burden of chronic diseases, the rise in surgical demand, and the trend towards ambulatory surgery centres are all driving the market expansion under study. According to an article published by the National Council on Aging research published in 2025, 93% of adults aged 65 and over have at least one health condition, and 79% are living with two or more. Additionally, the main market player’s strategic moves and the introduction of new products will further fuel market growth. According to the WHO statistics, it is anticipated that the increasing incidence rate of neurogenerative diseases such as Parkinson's disease, Alzheimer's disease, and dementia would accelerate market expansion over time.
Ownership and management shifts are reshaping the ambulatory surgical center market, with hospitals, private equity firms, and national ASC operators acquiring full or partial stakes in outpatient centers to expand reach and boost efficiency. A key example is Trinity Health of New England acquiring full ownership of its ASC at Johnson Memorial Hospital, enhancing service delivery and control.
This consolidation trend is driving up ambulatory surgical center market price, with physician-owned centers being valued highly, some fetching up to $275,000 per 1% ownership. These deals offer physicians capital liquidity and operational support while enabling investors to tap into the ASC model’s high margins and scalable structure.
Share
Share
About Author
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
